Copyright
©The Author(s) 2005.
World J Gastroenterol. Oct 7, 2005; 11(37): 5834-5839
Published online Oct 7, 2005. doi: 10.3748/wjg.v11.i37.5834
Published online Oct 7, 2005. doi: 10.3748/wjg.v11.i37.5834
Factors | FL n = 15 | NASH n = 15 | CH n = 14 | Healthy controls n = 10 | P ANOVA |
Protein C (%)a | 150±34 | 130±37 | 101±24 | 121±12 | 0.001 |
(normal 70-130) | |||||
Protein S (%)b | 106±20 | 92±19 | 95±37 | 90±17 | 0.01 |
(normal 60-140) | |||||
Anti-thrombin III (%) | 115±11 | 108±17 | 110±10 | 116±10 | NS |
(normal 80-120) | |||||
APC ratio | 2.2±0.1 | 2.2±0.9 | 2.2±0.3 | 2.2±0.1 | NS |
(normal >2.0) | |||||
Lupus anticoagulant | 1.0±0.1 | 1.05±0.1 | 1.0±0.1 | 1.0±0.1 | NS |
(normal <1.2 U/mL) | |||||
Fibrinogen | 336±69 | 326±57 | 296±49 | 291±69 | NS |
(normal 200-400 mg/dL) |
- Citation: Assy N, Bekirov I, Mejritsky Y, Solomon L, Szvalb S, Hussein O. Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases. World J Gastroenterol 2005; 11(37): 5834-5839
- URL: https://www.wjgnet.com/1007-9327/full/v11/i37/5834.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i37.5834